Discover the latest science based breakthroughs
in health, medicine and new drug approvals
Can Adding Pembrolizumab to Chemotherapy Improve Outcomes for Early Triple-Negative Breast Cancer?
What Did the Research Discover? This study examined whether adding...
Videos
How Zurzuvae Works: A New Treatment for Postpartum Depression
https://youtu.be/lYjDhyyrUBM
Promising Treatment for Alzheimer’s Disease Symptoms Revealed
https://youtu.be/hWWrtMKzrW8
Drug Approvals
Zepbound Injection Approved for Weight Loss in Overweight and Obese Adults on November 8, 2023
What is Zepbound prescribed for? Zepbound is prescribed...
Brixadi Approved for Treatment of Opioid Use Disorder on May 05, 2023
What is Brixadi prescribed for? Brixadi is indicated for the...
Latest Posts
Research Progress for Chronic Bronchitis: Sulforaphane Strengthens Lung Defenses
What did the research discover? Researchers studied how activating a...
Do All Men with Prostate Cancer Get the Same Treatment? A Look at Racial and Ethnic Gaps
What Are Current Prostate Cancer Treatments? Treating advanced...
New Light on Osteoarthritis: Innovative Imaging Techniques Unveil Early Joint Damage
What did the research discover? Researchers explored quantitative...
New Combination Therapy Shows Promise for Advanced Urinary Tract Cancer
What Did the Research Discover? Researchers conducted a phase 3...
New Discovery Could Lead to Better Treatments for Rheumatoid Arthritis
What did the research discover? Researchers created a detailed map...
Zepbound Injection Approved for Weight Loss in Overweight and Obese Adults on November 8, 2023
What is Zepbound prescribed for? Zepbound is prescribed...
New Hope for Alzheimer’s: Tackling Protein Clumps and Aging with Mitochondria Boosters
What did the research discover? This study explored how amyloid beta...
Effective Pain Relief for Nonspecific Low Back Pain: What Does the Research Say?
What Did the Research Discover? Low back pain is a common condition...
New Hope for Stomach Cancer: Combining Immunotherapy and Chemotherapy Before Surgery
What Did the Research Discover? Gastric and gastroesophageal...
Zonisamide for Epilepsy: Effectiveness, Safety, and Real-World Use
What Did the Research Discover? Zonisamide is an anti-seizure...
Faster Diagnosis of Acute Bronchitis: AI-Powered Tool Offers Rapid Results
What did the research discover? This study evaluated the...
Gene Therapy Offers New Hope for Retinitis Pigmentosa Patients
What Did the Research Discover? Researchers studied retinitis...
Gene Therapy Unlocks New Treatment for Inherited Blindness
What did the research discover? Scientists have been studying how...
Fast Relief from Itching: Dupilumab Shows Promise in Treating Bullous Pemphigoid
What Did the Research Discover? Bullous pemphigoid (BP) is a skin...
Can Doxycycline Help Manage Central Centrifugal Cicatricial Alopecia?
What Did the Research Discover? This study examined the...
Risk Factors for Chronic Low Back Pain: What You Should Know
What did the research discover? This study found that nearly...
Elafibranor: A Promising New Treatment for Primary Biliary Cholangitis
What Did the Research Discover? Primary biliary cholangitis (PBC) is...
Revolutionary Eye Drops May Offer Future Non-Surgical Treatment for Cataracts
What Did the Research Discover? Cataracts are a leading cause of...
ScienceMyHealth delivers the latest updates on new drug approvals and groundbreaking medical research from the Food and Drug Administration, leading scientific journals, and top universities.
With new stories and videos posted daily, subscribers can stay informed and receive alerts to explore and find clinical trials relevant to their interests.
Trending News
Can Adding Pembrolizumab to Chemotherapy Improve Outcomes for Early Triple-Negative Breast Cancer?
What Did the Research Discover? This study examined whether adding pembrolizumab (Keytruda), an immune checkpoint inhibitor, to standard chemotherapy before surgery could improve outcomes for patients with early-stage triple-negative breast cancer (TNBC). In this...
Research Progress for Chronic Bronchitis: Sulforaphane Strengthens Lung Defenses
What did the research discover? Researchers studied how activating a specific protein called Nrf2 could help the immune cells in the lungs, called alveolar macrophages, fight bacterial infections in chronic obstructive pulmonary disease (COPD). COPD makes it harder...
New Discovery Could Lead to Better Treatments for Rheumatoid Arthritis
What did the research discover? Researchers created a detailed map of the cells in the synovial tissue of people with rheumatoid arthritis (RA) by studying over 314,000 cells from 79 donors. They found six different types of cell patterns, called cell-type abundance...
New Hope for Stomach Cancer: Combining Immunotherapy and Chemotherapy Before Surgery
What Did the Research Discover? Gastric and gastroesophageal junction (G/GEJ) cancers are among the deadliest cancers, and while immunotherapy has become a standard treatment for advanced cases, its role in earlier-stage disease is not well understood. The PANDA trial...
FDA New Update: New Treatments, Safety Alerts, and Medical Advancements
For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust...
Gene Therapy Offers New Hope for Retinitis Pigmentosa Patients
What Did the Research Discover? Researchers studied retinitis pigmentosa (RP), an inherited eye disease that causes vision loss due to the death of light-sensitive cells in the retina. RP affects about 1 in 5,000 people worldwide, leading to symptoms like night...
Risk Factors for Chronic Low Back Pain: What You Should Know
What did the research discover? This study found that nearly one-third (32%) of patients with acute low back pain (LBP) transitioned to chronic LBP within six months. The risk of developing chronic pain was significantly associated with: Higher scores on the Subgroups...
Elafibranor: A Promising New Treatment for Primary Biliary Cholangitis
What Did the Research Discover? Primary biliary cholangitis (PBC) is a rare liver disease that gradually damages the bile ducts, leading to liver scarring. If left untreated, it can progress to cirrhosis and severe liver disease. The current first-line treatment,...